Stemleaf Bio Extracts Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 1076.50%
- Profit Growth 48.18%
- Ebitda 41.63%
- Net Worth -53.90%
- Total Assets -77.43%
About Stemleaf Bio Extracts
Stemleaf Bio Extracts Private Limited (SBEPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2017 (Seven years and six months 1 days old ). Its registered office is in Roorkee, Uttarakhand.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Tyagi and Samiksha Yadav serve as directors at the Company.
Company Details
- Location Roorkee, Uttarakhand
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UR2017PTC008025
-
Company No.
008025
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Stemleaf Bio Extracts?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Tyagi
|
Director | 14-Aug-2017 | Current |
|
Samiksha Yadav
|
Director | 14-Aug-2017 | Current |
Financial Performance of Stemleaf Bio Extracts.
Stemleaf Bio Extracts Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1076.5% increase. The company also saw a substantial improvement in profitability, with a 48.18% increase in profit. The company's net worth observed a substantial decline by a decrease of 53.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stemleaf Bio Extracts?
Unlock access to Stemleaf Bio Extracts's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Persca Global Private LimitedRahul Tyagi and Samiksha Yadav are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stemleaf Bio Extracts?
Unlock and access historical data on people associated with Stemleaf Bio Extracts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stemleaf Bio Extracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemleaf Bio Extracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
